In order to investigate the modulatory effect of purple sweet potato anthocyanins (PSPAs) on human intestinal microbiota, PSPAs were prepared by column chromatography and their influence on intestinal microbiota was analyzed by monitoring the bacterial populations and analyzing short-chain fatty acid (SCFA) concentrations at different time points. The numbers (log10 cell/mL) of Bifidobacterium and Lactobacillus/Enterococcus spp., Bacteroides-Prevotella, Clostridium histolyticum, and total bacteria after 24 h of culture in anaerobic fermentation broth containing PSPAs were 8.44 ± 0.02, 8.30 ± 0.01, 7.80 ± 0.03, 7.60 ± 0.03, and 9.00 ± 0.02, respectively, compared with 8.21 ± 0.03, 8.12 ± 0.02, 7.95 ± 0.02, 7.77 ± 0.02, and 9.01 ± 0.03, respectively, in the controls. The results showed that PSPAs induced the proliferation of Bifidobacterium and Lactobacillus/Enterococcus spp., inhibited the growth of Bacteroides-Prevotella and Clostridium histolyticum, and did not affect the total bacteria number. Total SCFA concentrations in the cultures with PSPAs were significantly higher than in the controls (P < 0.05). Moreover, during the fermentation, the PSPAs were partially fragmented to phenolic acids, which may exert a better effect on intestinal microecology, suggesting that PSPAs may have prebiotic-like activity by generating SCFAs and modulating the intestinal microbiota, contributing to improvements in human health.

(−)-Epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3″Me) has exhibited various biological activities in oolong tea. However, little information about its hepatoprotective activity is available. The objectives of the present study, therefore, were to determine the hepatoprotective activity of EGCG3″Me. First, high-purity EGCG3″Me was prepared from Chinese oolong tea by column chromatography. In antioxidant assay in vitro, EGCG3″Me exhibited potential antioxidant activity. For hepatoprotective activity in vitro, it was observed that EGCG3″Me effectively alleviated the changes induced by alcohol in a concentration-dependent manner. For hepatoprotective activity in vivo, the administration of EGCG3″Me at a dose of 100 mg/kg BW per day significantly decreased the serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) from 64.6 ± 3.17 and 97.6 ± 3.78 to 39.6 ± 2.72 and 59.6 ± 3.02 U/L, decreased the liver level of malondialdehyde (MDA) from 1.14 ± 0.08 to 0.77 ± 0.03 nmol/mg protein, and remarkably restored the liver activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) from 247 ± 20.1 U/mg and 6.12 ± 0.17 nmol/mg protein to 261 ± 9.98 U/mg and 8.10 ± 0.03 nmol/mg protein, respectively, in alcohol-induced liver injury mice. This suggested that the protective effect of EGCG3″Me against alcohol-induced liver injury is possibly via its antioxidant activity to protect biological systems against oxidative stress.

•The effect of EGCG3’’Me on high fat diet-induced obesity was investigated by high-throughput sequencing with HFA mice model.•EGCG3’’Me showed dramatically effects on the relative abundance of the dominant taxa at the phylum, family and genus levels.•EGCG3’’Me showed prebiotic-like activity and may be used as a functional food component for preventing gut dysbiosis.(-)-Epigallocatechin 3-O-(3-O-methyl) gallate (EGCG3″Me) has exhibited multiple beneficial effects on the prevention of obesity in oolong tea. However, its absorption is relatively low, and the potential to be fully utilized is not completely elucidated. Therefore, with human flora-associated (HFA) mice model, the effect of EGCG3″Me on high fat diet-induced obesity was investigated by high-throughput sequencing. The shifts in relative abundance of the dominant taxa at the phylum, family and genus levels showed the dramatically effects of EGCG3″Me. Despite significant inter-individual variation, a large increase in Bacteroidetes with concomitant decrease of Firmicutes was observed after the administration of EGCG3″Me for 8 weeks, with a corresponding decrease in the Firmicutes/Bacteroidetes ratio, which reflect the modulatory effect of EGCG3″Me on intestinal microbiota. The results showed that EGCG3″Me may have prebiotic-like activity and can be used as a functional food component with potential therapeutic utility in manipulating intestinal microbiota, contributing to the prevention of gut dysbiosis.Download high-res image (192KB)Download full-size image